HomeCompareORXOY vs SPHD

ORXOY vs SPHD: Dividend Comparison 2026

ORXOY yields 71.43% · SPHD yields 4.30%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ORXOY wins by $1.10M in total portfolio value
10 years
ORXOY
ORXOY
● Live price
71.43%
Share price
$2.80
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.12M
Annual income
$299,297.66
Full ORXOY calculator →
SPHD
SPHD
● Live price
4.30%
Share price
$49.61
Annual div
$2.14
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.5K
Annual income
$567.37
Full SPHD calculator →

Portfolio growth — ORXOY vs SPHD

📍 ORXOY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodORXOYSPHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ORXOY + SPHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ORXOY pays
SPHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ORXOY
Annual income on $10K today (after 15% tax)
$6,071.43/yr
After 10yr DRIP, annual income (after tax)
$254,403.01/yr
SPHD
Annual income on $10K today (after 15% tax)
$365.92/yr
After 10yr DRIP, annual income (after tax)
$482.26/yr
At 15% tax rate, ORXOY beats the other by $253,920.75/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ORXOY + SPHD for your $10,000?

ORXOY: 50%SPHD: 50%
100% SPHD50/50100% ORXOY
Portfolio after 10yr
$575.0K
Annual income
$149,932.51/yr
Blended yield
26.07%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ORXOY buys
0
SPHD buys
0
No recent congressional trades found for ORXOY or SPHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricORXOYSPHD
Forward yield71.43%4.30%
Annual dividend / share$2.00$2.14
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$1.12M$26.5K
Annual income after 10y$299,297.66$567.37
Total dividends collected$960.2K$5.0K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: ORXOY vs SPHD ($10,000, DRIP)

YearORXOY PortfolioORXOY Income/yrSPHD PortfolioSPHD Income/yrGap
1← crossover$17,843$7,142.86$11,130$430.50+$6.7KORXOY
2$31,003$11,911.12$12,357$447.82+$18.6KORXOY
3$52,515$19,342.29$13,687$464.65+$38.8KORXOY
4$86,812$30,620.19$15,126$480.98+$71.7KORXOY
5$140,194$47,305.90$16,682$496.78+$123.5KORXOY
6$221,406$71,397.66$18,362$512.03+$203.0KORXOY
7$342,284$105,380.00$20,174$526.72+$322.1KORXOY
8$518,499$152,255.26$22,127$540.84+$496.4KORXOY
9$770,345$215,550.93$24,230$554.39+$746.1KORXOY
10$1,123,567$299,297.66$26,493$567.37+$1.10MORXOY

ORXOY vs SPHD: Complete Analysis 2026

ORXOYStock

Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, Europe, and the United Kingdom. Its products include Zubsolv tablets for the treatment of opioid dependence; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of short-term insomnia. The company's development products comprise OX124, a medication for naloxone rescue; OX125, a medication for nalmefene rescue; OX640, a medication for allergic reactions; and OX338 sublingual tablet formulation of ketorolac for treatment of moderate to severe pain. It is also developing OX-MPI program for the treatment of microvascular diseases in chronic inflammatory conditions. The company's digital therapies comprise deprexis therapy for the treatment of mild to severe depression; vorvida for alcohol use disorder; and modia for opioid use disorder. Orexo AB (publ) was incorporated in 1994 and is headquartered in Uppsala, Sweden.

Full ORXOY Calculator →

SPHDETF

The Invesco S&P 500 High Dividend Low Volatility ETF (Fund) is based on the S&P 500 Low Volatility High Dividend Index (Index). The Fund will invest at least 90% of its total assets in common stocks that comprise the Index. Standard & Poor's compiles, maintains and calculates the Index, which is composed of 50 securities traded on the S&P 500 Index that historically have provided high dividend yields and low volatility. The Fund and the Index are rebalanced and reconstituted semi-annually, in January and July.

Full SPHD Calculator →
📬

Get this ORXOY vs SPHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ORXOY vs SCHDORXOY vs JEPIORXOY vs OORXOY vs KOORXOY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.